herpes zoster ophthalmicus
Conditions
Interventions
None listed
Sponsors
SRWS-PSG
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria were as follows: published and unpublished observational studies with a control, or controlled clinical studies, including only Abstracts or Letters; studies in any language, from any country, and including length of follow-up; and outpatients or inpatients suspected or diagnosed with acute herpes zoster ophthalmicus.
Exclusion criteria
Exclusion criteria: Exclusion criteria were as follows: case reports and case series; children and patients with existing uveitis, glaucoma, corneal, and retinal diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of ocular involvement, defined as a sign of ocular manifestation (e.g. conjunctivitis, superficial keratitis, episcleritis, stromal keratitis, dendritic ulcer, scleritis, uveitis, vasculitis, optic neuritis, chorioretinitis, acute retinal necrosis). Time point for analysis will be defined as 4 weeks or the closest time point to 4 weeks in a time span of 2 weeks to 6 months if data are not available. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of severe ocular involvement (intraocular involvement: e.g. scleritis, uveitis, vasculitis, optic neuritis, chorioretinitis, acute retinal necrosis) Time point for analysis will be defined as 4 weeks or the closest time point to 4 weeks in a time span of 2 weeks to 6 months if data are not available. | — |
Countries
Japan
Contacts
Public ContactTakahiro Mizuta
Tokyo Metropolitan Tama Medical Center Department of Dermatology
Outcome results
None listed